Most of the current drug-therapy glucose-lowering mechanisms for diabetes include targeting pancreatic β-cells, reducing pancreatic β-cell apoptosis, promoting β-cell proliferation and regeneration, and promoting insulin secretion. Here, INS is linked to diabetes mellitus.